Global Engineered T Cells Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Engineered T Cells Revenue
• 1.4 Market by Type
  • 1.4.1 Global Engineered T Cells Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Tumor Infiltrating Lymphocytes
  • 1.4.3 T Cell Receptor {TCR}
  • 1.4.4 Chimeric Antigen Receptor (CAR)
• 1.5 Market by Application
  • 1.5.1 Global Engineered T Cells Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Cancer Research Centers
  • 1.5.4 Clinics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Engineered T Cells Market Perspective (2015-2026)
• 2.2 Global Engineered T Cells Growth Trends by Regions
  • 2.2.1 Engineered T Cells Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Engineered T Cells Historic Market Share by Regions (2015-2020)
  • 2.2.3 Engineered T Cells Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Engineered T Cells Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Engineered T Cells Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Engineered T Cells Players by Market Size
  • 3.1.1 Global Top Engineered T Cells Players by Revenue (2015-2020)
  • 3.1.2 Global Engineered T Cells Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Engineered T Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Engineered T Cells Market Concentration Ratio
  • 3.2.1 Global Engineered T Cells Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Engineered T Cells Revenue in 2019
• 3.3 Engineered T Cells Key Players Head office and Area Served
• 3.4 Key Players Engineered T Cells Product Solution and Service
• 3.5 Date of Enter into Engineered T Cells Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Engineered T Cells Historic Market Size by Type (2015-2020)
• 4.2 Global Engineered T Cells Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Engineered T Cells Market Size by Application (2015-2020)
• 5.2 Global Engineered T Cells Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Engineered T Cells Market Size (2015-2020)
• 6.2 Engineered T Cells Key Players in North America (2019-2020)
• 6.3 North America Engineered T Cells Market Size by Type (2015-2020)
• 6.4 North America Engineered T Cells Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Engineered T Cells Market Size (2015-2020)
• 7.2 Engineered T Cells Key Players in Europe (2019-2020)
• 7.3 Europe Engineered T Cells Market Size by Type (2015-2020)
• 7.4 Europe Engineered T Cells Market Size by Application (2015-2020)

8 China

• 8.1 China Engineered T Cells Market Size (2015-2020)
• 8.2 Engineered T Cells Key Players in China (2019-2020)
• 8.3 China Engineered T Cells Market Size by Type (2015-2020)
• 8.4 China Engineered T Cells Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Engineered T Cells Market Size (2015-2020)
• 9.2 Engineered T Cells Key Players in Japan (2019-2020)
• 9.3 Japan Engineered T Cells Market Size by Type (2015-2020)
• 9.4 Japan Engineered T Cells Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Engineered T Cells Market Size (2015-2020)
• 10.2 Engineered T Cells Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Engineered T Cells Market Size by Type (2015-2020)
• 10.4 Southeast Asia Engineered T Cells Market Size by Application (2015-2020)

11 India

• 11.1 India Engineered T Cells Market Size (2015-2020)
• 11.2 Engineered T Cells Key Players in India (2019-2020)
• 11.3 India Engineered T Cells Market Size by Type (2015-2020)
• 11.4 India Engineered T Cells Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Engineered T Cells Market Size (2015-2020)
• 12.2 Engineered T Cells Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Engineered T Cells Market Size by Type (2015-2020)
• 12.4 Central & South America Engineered T Cells Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Autolus Limited
  • 13.1.1 Autolus Limited Company Details
  • 13.1.2 Autolus Limited Business Overview
  • 13.1.3 Autolus Limited Engineered T Cells Introduction
  • 13.1.4 Autolus Limited Revenue in Engineered T Cells Business (2015-2020))
  • 13.1.5 Autolus Limited Recent Development
• 13.2 Bellicum Pharmaceuticals
  • 13.2.1 Bellicum Pharmaceuticals Company Details
  • 13.2.2 Bellicum Pharmaceuticals Business Overview
  • 13.2.3 Bellicum Pharmaceuticals Engineered T Cells Introduction
  • 13.2.4 Bellicum Pharmaceuticals Revenue in Engineered T Cells Business (2015-2020)
  • 13.2.5 Bellicum Pharmaceuticals Recent Development
• 13.3 Cells Medica
  • 13.3.1 Cells Medica Company Details
  • 13.3.2 Cells Medica Business Overview
  • 13.3.3 Cells Medica Engineered T Cells Introduction
  • 13.3.4 Cells Medica Revenue in Engineered T Cells Business (2015-2020)
  • 13.3.5 Cells Medica Recent Development
• 13.4 Elli Lilly and Company
  • 13.4.1 Elli Lilly and Company Company Details
  • 13.4.2 Elli Lilly and Company Business Overview
  • 13.4.3 Elli Lilly and Company Engineered T Cells Introduction
  • 13.4.4 Elli Lilly and Company Revenue in Engineered T Cells Business (2015-2020)
  • 13.4.5 Elli Lilly and Company Recent Development
• 13.5 Gilead Sciences
  • 13.5.1 Gilead Sciences Company Details
  • 13.5.2 Gilead Sciences Business Overview
  • 13.5.3 Gilead Sciences Engineered T Cells Introduction
  • 13.5.4 Gilead Sciences Revenue in Engineered T Cells Business (2015-2020)
  • 13.5.5 Gilead Sciences Recent Development
• 13.6 Juno Therapeutics
  • 13.6.1 Juno Therapeutics Company Details
  • 13.6.2 Juno Therapeutics Business Overview
  • 13.6.3 Juno Therapeutics Engineered T Cells Introduction
  • 13.6.4 Juno Therapeutics Revenue in Engineered T Cells Business (2015-2020)
  • 13.6.5 Juno Therapeutics Recent Development
• 13.7 Novartis
  • 13.7.1 Novartis Company Details
  • 13.7.2 Novartis Business Overview
  • 13.7.3 Novartis Engineered T Cells Introduction
  • 13.7.4 Novartis Revenue in Engineered T Cells Business (2015-2020)
  • 13.7.5 Novartis Recent Development
• 13.8 Oxford Biomedica
  • 13.8.1 Oxford Biomedica Company Details
  • 13.8.2 Oxford Biomedica Business Overview
  • 13.8.3 Oxford Biomedica Engineered T Cells Introduction
  • 13.8.4 Oxford Biomedica Revenue in Engineered T Cells Business (2015-2020)
  • 13.8.5 Oxford Biomedica Recent Development
• 13.9 Pfizer
  • 13.9.1 Pfizer Company Details
  • 13.9.2 Pfizer Business Overview
  • 13.9.3 Pfizer Engineered T Cells Introduction
  • 13.9.4 Pfizer Revenue in Engineered T Cells Business (2015-2020)
  • 13.9.5 Pfizer Recent Development
• 13.10 Precision Bioscience
  • 13.10.1 Precision Bioscience Company Details
  • 13.10.2 Precision Bioscience Business Overview
  • 13.10.3 Precision Bioscience Engineered T Cells Introduction
  • 13.10.4 Precision Bioscience Revenue in Engineered T Cells Business (2015-2020)
  • 13.10.5 Precision Bioscience Recent Development
• 13.11 Redmile Group
  • 10.11.1 Redmile Group Company Details
  • 10.11.2 Redmile Group Business Overview
  • 10.11.3 Redmile Group Engineered T Cells Introduction
  • 10.11.4 Redmile Group Revenue in Engineered T Cells Business (2015-2020)
  • 10.11.5 Redmile Group Recent Development
• 13.12 Seeking Alpha
  • 10.12.1 Seeking Alpha Company Details
  • 10.12.2 Seeking Alpha Business Overview
  • 10.12.3 Seeking Alpha Engineered T Cells Introduction
  • 10.12.4 Seeking Alpha Revenue in Engineered T Cells Business (2015-2020)
  • 10.12.5 Seeking Alpha Recent Development
• 13.13 Unum Therapeutics
  • 10.13.1 Unum Therapeutics Company Details
  • 10.13.2 Unum Therapeutics Business Overview
  • 10.13.3 Unum Therapeutics Engineered T Cells Introduction
  • 10.13.4 Unum Therapeutics Revenue in Engineered T Cells Business (2015-2020)
  • 10.13.5 Unum Therapeutics Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer